This page shows the latest Chase Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.
The upfront payments were $100m and $15m, respectively. Similarly Allergan has not made public the overall headline value of its acquisition of Chase Pharmaceuticals, opting instead to refer to the upfront ... equity investment, 2 year collaboration. 145.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
And Scott Giacobello joins as chief financial officer. UK biopharma company GW Pharmaceuticals has promoted chief financial officer Adam George to UK managing director. ... Giacobello, meanwhile, has 25 years experience in finance and operations, most
Scott Giacobello and Gary Charbonneau join. Californian Chase Pharmaceuticals has made two appointments to its senior leadership team. ... Charbonneau joins Chase with over 25 years of experience in regulatory, quality and research and development
Douglas Ingram joins as chief executive officer. Washington-based Chase Pharmaceuticals has appointed Douglas Ingram as its new chief executive officer to replace John Siebert, who will continue working with the ... Ingram said: “I am privileged to
More from appointments
Approximately 2 fully matching, plus 1 partially matching documents found.
No results were found
JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...